Eaton Vance Management Lantheus Holdings, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $60,821 - $141,883	-2,505 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $4,440 - $5,996	197 Added 8.54%	2,505 $0
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $3,561 - $4,202	147 Added 6.8%	2,308 $0
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $29,733 - $42,123	1,524 Added 239.25%	2,161 $60,000
Q1 2021 May 17, 2021	BUY	$13.77 - $21.66 $8,771 - $13,797	637 New	637 $14,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.13B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.